Found 41 matching trials
A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months PHASE3 This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Show More Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Learn More & Join Trial
Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination PHASE3 The purpose/aim of this study is to assess the safety and antibody response...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Understanding the Immune Response to Two Different Meningitis Vaccines PHASE4 The bacterium (germ) Neisseria meningitidis causes meningitis and blood poi...
Show More Location
Oxford Vaccine Group
Treatments Being Tested
MenACWY-CRM conjugate vaccine (Menveo, Novartis) MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) 1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis) Polysaccharide (subcutaneously)-conjugate Learn More & Join Trial
MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age PHASE3 The aim of this study is to determine the immunologic noninferiority of Men...
Show More Location
Alabama Clinical Therapeutics, LLC, Birmington Pediatric Assocaites
Learn More & Join Trial
Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age PHASE3 Safety and immunogenicity of meningococcal ACWY conjugate versus polysaccha...
Show More Location
FUNCEI, French 3085
Learn More & Join Trial
Adolescent MenACWY Booster Study PHASE4 This study is to confirm non-inferiority of the three MenACWY vaccines (Men...
Show More Location
Children's Hospital Research Institute, University of Calgary
Learn More & Join Trial
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children PHASE3 To evaluate the safety and immune response of Novartis MenACWY conjugate va...
Show More Location
Children's Investigational Reserach Program
Learn More & Join Trial
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine PHASE3 This study compares the safety and immunogenicity profile of combined hepat...
Show More Location
03, Novartis Investigational Site
Learn More & Join Trial
Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose PHASE4 In this extension study, V59P20E1, the sponsor was planning to assess 5-yea...
Show More Location
82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300
Learn More & Join Trial
Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older N/A A multicenter, single arm, postmarketing surveillance study. This study is ...
Show More Location
Multiple Locations
Learn More & Join Trial